SecurityIII / Information Services Group, Inc. (45675Y104)
Chairman & CEOCONNORS MICHAEL P
IndustryManagement Consulting Services
Institutional Owners77
Institutional Shares23,012,804 - 51.02%
Common Shares Outstanding45,102,239 shares (as of 2018-06-30)
Institutional Value$ 4,572,364,000 USD
Related IIIU / Information Services Group, Inc.

Institutional Stock Ownership and Shareholders

III / Information Services Group, Inc. Institutional Ownership

Information Services Group, Inc. (NASDAQ:III) has 77 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 23,012,804 shares. Largest shareholders include Private Capital Management, LLC, Renaissance Technologies LLC, Vanguard Group Inc, BlackRock Inc., Thomson Horstmann & Bryant Inc, Northern Right Capital Management, L.P., Blair William & Co/il, Llr Management, L.p., Weber Alan W, and Punch & Associates Investment Management, Inc..
Information Services Group, Inc. (NASDAQ:III) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-10 13F-HR ClariVest Asset Management LLC 0 46,497 0 191
2018-08-14 13F-HR PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 1,007,000 1,007,000 0.00 4,209 4,129 -1.90
2018-07-18 13F-HR Fny Investment Advisers, Llc 60,165 246
2018-08-01 13F-HR Minerva Advisors LLC 27,294 27,294 0.00 114 112 -1.75
2018-08-14 13F-HR JP Morgan Chase & Co 6,986 7,276 4.15 29 30 3.45
2018-08-13 13F-HR CAPTRUST FINANCIAL ADVISORS 9,800 40
2018-08-14 13F-HR TEACHERS ADVISORS INC 71,726 67,221 -6.28 300 276 -8.00
2017-02-07 13F-HR FIRST NEW YORK SECURITIES LLC /NY 49,461 180,038
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 242,785 245,005 0.91 969 892 -7.95
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA 7,018 1,015 -85.54 29,335 4,162 -85.81
2018-08-09 13F-HR WEBER ALAN W 1,046,050 1,046,050 0.00 4,372 4,288,805 97,997.10
2018-08-01 13F-HR Wagner Wealth Management, Llc 550 550 0.00 2 2 0.00
2018-08-10 13F-HR WOODMONT INVESTMENT COUNSEL LLC 13,879 0 -100.00 58 0 -100.00
2018-07-24 13F-HR MEEDER ASSET MANAGEMENT INC 0 2,406 0 9,865
2018-08-14 13F-HR Equitable Trust Co 177,117 726
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 83,764 165,795 97.93 350 680 94.29
2018-08-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 51,449 51,449 0.00 215 211 -1.86
2018-08-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 18,749 18,784 0.19 78 77 -1.28
2018-08-13 13F-HR RAYMOND JAMES & ASSOCIATES 17,362 11,512 -33.69 73 47 -35.62
2018-08-14 13F-HR DEUTSCHE BANK AG\ 35,419 136,842 286.35 146 560 283.56
2018-07-30 13F-HR/A Virtu Financial LLC 11,604 48
2018-08-14 13F-HR Invesco Ltd. 0 12,068 0 49
2018-08-09 13F-HR MARTINGALE ASSET MANAGEMENT L P 110,416 453
2018-08-14 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 215,800 215,800 0.00 902 885 -1.88
2018-08-13 13F-HR EARNEST PARTNERS LLC 1,700 1,700 0.00 7 7 0.00
2018-08-14 13F-HR VANGUARD GROUP INC 1,573,505 1,757,924 11.72 6,577 7,207 9.58
2018-07-31 13F-HR LOS ANGELES CAPITAL MANAGEMENT & EQUITY RESEARCH INC 36,198 36,198 0.00 151 148 -1.99
2018-08-14 13F-HR MACQUARIE GROUP LTD 5,909 96,358 1,530.70 25 395 1,480.00
2018-08-14 13F-HR UBS Group AG 0 4,260 0 17
2017-02-10 13F-HR BlackRock Investment Management, LLC 117,762 119,115 1.15 470 434 -7.66
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 218,742 239,347 9.42 914 981 7.33
2018-08-10 13F-HR Ancora Advisors, LLC 27,121 0 -100.00 113 0 -100.00
2017-02-10 13F-HR BlackRock Advisors LLC 11,951 12,273 2.69 48 45 -6.25
2018-05-11 13F-HR CITIGROUP INC 56,353 82,409 46.24 235 344 46.38
2018-07-25 13F-HR BESSEMER GROUP INC 9,720 49,620 410.49 41 204 397.56
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 62,572 60,064 -4.01 261 246 -5.75
2018-08-13 13F-HR Renaissance Technologies LLC 1,922,411 8,036
2018-08-13 13F-HR BLAIR WILLIAM & CO/IL 1,381,609 1,421,480 2.89 5,775 5,828 0.92
2018-07-27 13F-HR PIEDMONT INVESTMENT ADVISORS LLC 583 2
2017-10-26 13F-HR Acrospire Investment Management LLC 5,170 0 -100.00 21 0 -100.00
2018-08-14 13F-HR MORGAN STANLEY 82,340 97,927 18.93 344 401 16.57
2018-09-18 13F-HR/A NORTHERN TRUST CORP 375,632 375,826 0.05 1,570 1,541 -1.85
2018-08-13 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 0 11,125 0 46
2018-08-10 13F-HR THOMSON HORSTMANN & BRYANT INC 1,718,557 1,664,769 -3.13 7,183 6,825 -4.98
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 27,467 29,937 8.99 115 123 6.96
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 11,745 0 -100.00 49 0 -100.00
2018-08-10 13F-HR OPPENHEIMER ASSET MANAGEMENT INC. 18,511 0 -100.00 77 0 -100.00
2018-08-13 13F-HR Axa 21,898 187,798 757.60 92 770 736.96
2018-08-08 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 86,512 86,512 0.00 362 355 -1.93
2018-04-18 13F-HR/A FNY Partners Fund LP 152,958 120,151 -21.45 637 502 -21.19
2018-07-24 13F-HR ACADIAN ASSET MANAGEMENT LLC 26,462 49,892 88.54 111 204 83.78
2018-08-14 13F-HR BARCLAYS PLC 6,893 2,457 -64.36 29 10 -65.52
2018-08-10 13F-HR CITIGROUP INC 82,409 64,419 -21.83 344 264 -23.26
2018-02-14 13F-HR Llr Management, L.p. 1,220,778 5,115
2018-08-14 13F-HR Zebra Capital Management LLC 14,124 0 -100.00 59 0 -100.00
2018-08-08 13F-HR AMERICAN INTERNATIONAL GROUP INC 20,721 21,869 5.54 87 90 3.45
2018-08-14 13F-HR CREDIT SUISSE AG/ 12,443 10,578 -14.99 52 44 -15.38
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 1,874 1,874 0.00 8 8 0.00
2018-08-13 13F-HR McGowan Group Asset Management, Inc. 62,843 62,843 0.00 263 258 -1.90
2018-08-14 13F-HR PERRITT CAPITAL MANAGEMENT INC 326,715 351,215 7.50 1,349 1,440 6.75
2017-02-10 13F-HR BlackRock Fund Advisors 845,829 1,005,934 18.93 3,375 3,662 8.50
2017-08-18 13F-HR WFG Advisors, LP 3,200 6,100 90.62 10 25 150.00
2018-08-10 13F-HR DIMENSIONAL FUND ADVISORS LP 50,369 239,680 375.85 211 983 365.88
2018-08-09 13F-HR BlackRock Inc. 1,463,227 1,731,099 18.31 6,117 7,097 16.02
2018-08-15 13F-HR GLENMEDE TRUST CO NA 0 1 0 0
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 66,267 66,267 0.00 277 277 0.00
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 0 237 0 1
2018-08-14 13F-HR Northern Right Capital Management, L.P. 1,580,784 1,597,947 1.09 6,608 6,552 -0.85
2018-08-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 99,579 71,523 -28.17 416 293 -29.57
2018-08-14 13F-HR ROYAL BANK OF CANADA 20 62 210.00 0 0
2018-07-31 13F-HR WEDGE CAPITAL MANAGEMENT L L P/NC 179,800 179,800 0.00 752 737 -1.99
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 0 16,921 0 69
2018-08-14 13F-HR Private Capital Management, LLC 2,480,384 3,281,644 32.30 10,368 13,455 29.77
2018-08-06 13F-HR RHUMBLINE ADVISERS 27,633 32,463 17.48 116 133 14.66
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 24,657 15,984 -35.17 103 65 -36.89
2018-08-14 13F-HR STATE STREET CORP 481,552 478,428 -0.65 2,016 1,961 -2.73
2018-07-20 13F-HR Creative Planning 33,600 46,900 39.58 140 192 37.14
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 31,700 31,700 0.00 133 130 -2.26
2018-08-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 130,200 130,200 0.00 544 534 -1.84
2018-08-03 13F-HR Clear Harbor Asset Management, LLC 119,435 119,435 0.00 499 490 -1.80
2018-08-10 13F-HR Legal & General Group Plc 5,591 5,591 0.00 23 23 0.00
2018-07-24 13F-HR WETHERBY ASSET MANAGEMENT INC 194,450 194,450 0.00 813 797 -1.97
2018-08-08 13F-HR Russell Investments Group, Ltd. 1,121,102 113,178 -89.90 4,686 464 -90.10
2018-08-13 13F-HR Ameritas Investment Partners, Inc. 2,421 2,421 0.00 10 10 0.00

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

6 Reasons Why You Should Buy FTI Consulting (FCN) Stock

2018-09-19 zacks
A prudent investment decision involves buying well-performing stocks at the right time, while selling those that are at risk. A rise in share price and strong fundamentals signal a stock’s bullish run. (1-0)

III vs. ACN: Which Stock Is the Better Value Option?

2018-09-17 zacks
Investors with an interest in Consulting Services stocks have likely encountered both Information Services Group (III - Free Report) and Accenture (ACN - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. (2-0)

B. Riley Financial: This 6.875% Baby Bond Has Begun Trading On The Nasdaq

2018-09-14 seekingalpha
Comparison with all other baby bonds that pay a fixed rate and have less than 10 years to maturity. (7-0)

Here's Why You Should Retain Aptiv (APTV) in Your Portfolio

2018-09-13 zacks
A prudent investment decision involves buying stocks that have solid prospects and selling those that carry risks. At times, it is rational to hold certain stocks that have enough potential but are weighed down by tough market conditions. (1-0)

FISV or EFX: Which Financial Services Firm is Better Placed?

2018-09-06 zacks
The financial services industry has transformed significantly in the recent years, considering the notable changes in transaction techniques. (5-0)

6 Reasons Why You Should Buy CRA International (CRAI) Now

2018-09-05 zacks
A prudent investment decision involves buying well-performing stocks at the right time while selling those that are at risk. A rise in share price and strong fundamentals signal a stock’s bullish run. (1-0)

Is Information Services Group (III) Stock Undervalued Right Now?

2018-09-03 zacks
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. (1-0)

Here's Why Investors Should Retain First Data (FDC) Stock

2018-08-30 zacks
A prudent investment decision involves buying stocks that have solid prospects and selling those that carry risks. At times, it is rational to hold certain stocks that have enough potential but are weighed down by tough market conditions. (9-0)

Here's Why Hold Strategy Is Apt for Fang Holdings (SFUN) Now

2018-08-30 zacks
A prudent investment decision involves buying stocks that have solid prospects and selling those that carry risks. At times, it is rational to hold certain stocks that have enough potential but are weighed down by tough market conditions. (5-0)

FTI Consulting Rides on International Operations, Tax Cut

2018-08-30 zacks
FTI Consulting, Inc. (FCN - Free Report) stock has rallied 74.4% on a year-to-date basis, outperforming the 12.4% rise of the industry it belongs to. (1-0)

CUSIP: 45675Y104